Stay updated on Nivolumab in Resectable NSCLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Resectable NSCLC Clinical Trial page.

Latest updates to the Nivolumab in Resectable NSCLC Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5 in the page metadata.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4 on the page, indicating a new version of the page snapshot. This appears to be a metadata change rather than a substantive update to the study details.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page footer now displays revision v3.6.3 instead of v3.6.2, indicating a small release update to the page.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page footer now shows Revision: v3.6.2, replacing the previous Revision: v3.6.0, indicating an update to the page’s template/versioning.SummaryDifference0.0%

- Check68 days agoChange DetectedThe study page now indicates that recruitment has ended and adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study). The Study Plan area is updated to include an Intervention/Treatment label, and the revision note updates to v3.6.0.SummaryDifference0.3%

- Check75 days agoChange DetectedThe page’s revision label changed from v3.5.4 to v3.5.5, indicating a behind-the-scenes update to the site’s software or layout rather than a change to study content or details.SummaryDifference0.0%

Stay in the know with updates to Nivolumab in Resectable NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Resectable NSCLC Clinical Trial page.